Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis.
about
Adoptive transfer of dendritic cells modulates immunogenesis and tolerogenesis in a neonatal model of murine cutaneous leishmaniasisLXR deficiency confers increased protection against visceral Leishmania infection in mice.A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensisDouble blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629]New approaches from nanomedicine for treating leishmaniasis.Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STAT pathways.
P2860
Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis.
@en
Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis.
@nl
type
label
Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis.
@en
Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis.
@nl
prefLabel
Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis.
@en
Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis.
@nl
P2093
P2860
P1476
Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2230.2003.01206.X
P577
2003-05-01T00:00:00Z